Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms

被引:169
作者
Hamamoto, H [1 ]
Kurokawa, K [1 ]
Kaito, C [1 ]
Kamura, K [1 ]
Razanajatovo, LM [1 ]
Kusuhara, H [1 ]
Santa, T [1 ]
Sekimizu, K [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
关键词
D O I
10.1128/AAC.48.3.774-779.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The injection of bacteria (Staphylococcus aureus, Stenotrophomonas maltophilia) or true fungi (Candida albicans, Candida tropicalis) that are pathogenic to humans into the silkworm hemolymph leads to death of the larvae within 2 days. Antibiotics used for clinical purposes have therapeutic effects on silkworms infected with these pathogens. The 50% effective doses obtained by injection into the silkworm hemolymph are consistent with those reported for mice. Injection of vancomycin and kanamycin into the silkworm hemolymph was effective, but oral administration was not. Chloramphenicol, which is effective by oral administration, appeared in the silkworm hemolymph soon after injection into the midgut, whereas vancomycin did not. Isolated midgut membranes were impermeable to vancomycin. Thus, the ineffectiveness of oral administration of vancomycin to silkworms is due to a lack of intestinal absorption.
引用
收藏
页码:774 / 779
页数:6
相关论文
共 16 条
[1]   Increase in resistance of methicillin-resistant Staphylococcus aureus to β-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals [J].
Akimitsu, N ;
Hamamoto, H ;
Inoue, R ;
Shoji, M ;
Akamine, A ;
Takemori, K ;
Hamasaki, N ;
Sekimizu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :3042-3043
[2]  
[Anonymous], 1998, HUMAN USE ANIMALS CA
[3]   Synthesis and antimicrobial activity of a {2-[2-(N,N-disubstituted thiocarbamoyl-sulfanyl)-acylamino]thiazol-4-yl}acetic acid ethyl esters [J].
Ates, Ö ;
Gürsoy, A ;
Altintas, H ;
Ötük, G ;
Birteksöz, S .
ARCHIV DER PHARMAZIE, 2003, 336 (01) :39-46
[4]   Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity [J].
Bernal, A ;
Kimbrell, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :6019-6024
[5]   In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections [J].
Ford, CW ;
Hamel, JC ;
Wilson, DM ;
Moerman, JK ;
Stapert, D ;
Yancey, RJ ;
Hutchinson, DK ;
Barbachyn, MR ;
Brickner, SJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1508-1513
[6]   Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis [J].
Ikeda, F ;
Wakai, Y ;
Matsumoto, S ;
Maki, K ;
Watabe, E ;
Tawara, S ;
Goto, T ;
Watanabe, Y ;
Matsumoto, F ;
Kuwahara, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :614-618
[7]   Silkworm larvae as an animal model of bacterial infection pathogenic to humans [J].
Kaito, C ;
Akimitsu, N ;
Watanabe, H ;
Sekimizu, K .
MICROBIAL PATHOGENESIS, 2002, 32 (04) :183-190
[8]   The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults [J].
Lemaitre, B ;
Nicolas, E ;
Michaut, L ;
Reichhart, JM ;
Hoffmann, JA .
CELL, 1996, 86 (06) :973-983
[9]  
Levitt David G, 2003, BMC Clin Pharmacol, V3, P3, DOI 10.1186/1472-6904-3-3
[10]   Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa Caenorhabditis elegans pathogenesis model [J].
Mahajan-Miklos, S ;
Tan, MW ;
Rahme, LG ;
Ausubel, FM .
CELL, 1999, 96 (01) :47-56